undefined undefined
NaN.000
NaN.00%
HC Wainwright & Co. analyst Edward White reiterates InflaRx (NASDAQ:IFRX) with a Buy and maintains $8 price target.
05-09 18:52
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a biopharmaceutical c...
05-08 21:58
InflaRx press release (NASDAQ:IFRX): Q1 GAAP EPS of -€0.17 beats by $0.07. Revenue of €36.03M beats by €35.89M. More on InflaRx Seeking Alpha’s Quant Rating on InflaRx Historical earnings data for Inf...
05-08 19:36
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a Dutch-based public ...
04-26 05:31
In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold ...
03-23 03:05
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a biotech company spe...
03-22 09:27
Losers: Destination XL Group (DXLG) -16% after Q4 earnings release. Tourmaline Bio (TRML) -30%. Apyx Medical Corp (APYX) -17% after Q4 earnings release. Five Below (FIVE) -12% after Q4 earnings releas...
03-21 20:43
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a biotech firm target...
03-21 19:57
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
03-21 18:15
InflaRx (NASDAQ:IFRX) is set to give its latest quarterly earnings report on Th...
03-21 01:01